BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 11212248)

  • 1. Transforming growth factor-beta1 induces desmoplasia in an experimental model of human pancreatic carcinoma.
    Löhr M; Schmidt C; Ringel J; Kluth M; Müller P; Nizze H; Jesnowski R
    Cancer Res; 2001 Jan; 61(2):550-5. PubMed ID: 11212248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble type II transforming growth factor-beta (TGF-beta) receptor inhibits TGF-beta signaling in COLO-357 pancreatic cancer cells in vitro and attenuates tumor formation.
    Rowland-Goldsmith MA; Maruyama H; Kusama T; Ralli S; Korc M
    Clin Cancer Res; 2001 Sep; 7(9):2931-40. PubMed ID: 11555612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular matrix-mediated membrane-type 1 matrix metalloproteinase expression in pancreatic ductal cells is regulated by transforming growth factor-beta1.
    Ottaviano AJ; Sun L; Ananthanarayanan V; Munshi HG
    Cancer Res; 2006 Jul; 66(14):7032-40. PubMed ID: 16849548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of interleukin 10 and transforming growth factor beta1 in the angiogenesis and metastasis of human prostate primary tumor lines from orthotopic implants in severe combined immunodeficiency mice.
    Stearns ME; Garcia FU; Fudge K; Rhim J; Wang M
    Clin Cancer Res; 1999 Mar; 5(3):711-20. PubMed ID: 10100726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.
    Paterson IC; Davies M; Stone A; Huntley S; Smith E; Pring M; Eveson JW; Robinson CM; Parkinson EK; Prime SS
    Oncogene; 2002 Feb; 21(10):1616-24. PubMed ID: 11896591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells.
    Ye SC; Foster JM; Li W; Liang J; Zborowska E; Venkateswarlu S; Gong J; Brattain MG; Willson JK
    Cancer Res; 1999 Sep; 59(18):4725-31. PubMed ID: 10493532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-beta1 increases survival of human melanoma through stroma remodeling.
    Berking C; Takemoto R; Schaider H; Showe L; Satyamoorthy K; Robbins P; Herlyn M
    Cancer Res; 2001 Nov; 61(22):8306-16. PubMed ID: 11719464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic exposure of transforming growth factor beta 1 confers a more aggressive tumor phenotype through downregulation of p21(WAF1/CIP1) in conditionally immortalized pancreatic epithelial cells.
    Ito D; Fujimoto K; Doi R; Koizumi M; Toyoda E; Mori T; Kami K; Kawaguchi Y; Whitehead R; Imamura M
    Surgery; 2004 Aug; 136(2):364-74. PubMed ID: 15300203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated expression of TGF-beta1 in head and neck cancer-associated fibroblasts.
    Rosenthal E; McCrory A; Talbert M; Young G; Murphy-Ullrich J; Gladson C
    Mol Carcinog; 2004 Jun; 40(2):116-21. PubMed ID: 15170816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.
    Tobin SW; Douville K; Benbow U; Brinckerhoff CE; Memoli VA; Arrick BA
    Oncogene; 2002 Jan; 21(1):108-18. PubMed ID: 11791181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-host interaction mediates the regression of BK virus-induced vascular tumors in mice: involvement of transforming growth factor-beta1.
    Corallini A; Possati L; Trabanelli C; Giraudo E; Rocchetti R; Talevi S; Caputo A; Bussolino F; Barbanti-Brodano G
    Carcinogenesis; 2003 Sep; 24(9):1435-44. PubMed ID: 12844479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
    Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
    Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor-II/mannose 6 phosphate receptors facilitate the matrix effects of latent transforming growth factor-beta1 released from genetically modified keratinocytes in a fibroblast/keratinocyte co-culture system.
    Ghahary A; Tredget EE; Shen Q
    J Cell Physiol; 1999 Jul; 180(1):61-70. PubMed ID: 10362018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid.
    Huang F; Newman E; Theodorescu D; Kerbel RS; Friedman E
    Cell Growth Differ; 1995 Dec; 6(12):1635-42. PubMed ID: 9019169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-beta1 down-regulates ICAM-1 expression and enhances liver metastasis of pancreatic cancer.
    Sawada T; Kimura K; Nishihara T; Onoda N; Teraoka H; Yamashita Y; Yamada N; Yashiro M; Ohira M; Hirakawa K
    Adv Med Sci; 2006; 51():60-5. PubMed ID: 17357279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
    Fujiwara M; Muragaki Y; Ooshima A
    Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.
    Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA
    Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
    Yang F; Strand DW; Rowley DR
    Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
    Chujo S; Shirasaki F; Kawara S; Inagaki Y; Kinbara T; Inaoki M; Takigawa M; Takehara K
    J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.